Surrogate markers to monitor efficacy of anticoagulants or antiplatelet drugs in atrial fibrillation

the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002; 23: 892–900. [15] Zile M, Blaustein A, Shimizu G et al. Right ventricular pacing reduces the rate of left ventricular relaxation and filling. J Am Coll Cardiol 1987; 10: 702–9. [16] Ausubel K, Furman S. The pacemaker syndrome. Ann Intern Med 1985; 103: 420–9. [17] Vanderheiden M, Goethals M, Anguera I et al. Hemodynamic deterioration following radiofrequency ablation of the atrioventricular conduction system. PACE 1997; 20: 2422–38. [18] Sadaniantz A, Laurent L. Left ventricular doppler diastolic filling patterns in patients with isolated left bundle branch block. Am J Cardiol 1998; 81: 643–5. [19] Blanc JJ, Etienne Y, Gilard M et al. Evaluation of different ventricular pacing sites in patients with severe heart failure. Results of an acute haemodynamic study. Circulation 1997; 96: 3273–7. [20] Etienne Y, Mansourati J, Gilard M et al. Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation. Am J Cardiol 1999; 83: 1138–40. [21] Kass D, Chen-Huan C, Curry C et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999; 99: 1567–73. [22] Auricchio A, Stellbrink C, Block M et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999; 99: 2993–3001. [23] Brignole M, Gammage M. An assessment of the optimal ventricular pacing site in patients undergoing ‘ablate and pace‘ therapy for permanent atrial fibrillation. Europace 2001; 3: 153–6. [24] Gras D, Mabo P, Tang T et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. PACE 1998; 21: 2249–55. [25] Reuter S, Garrigue S, Bordachar P et al. Intermediate-term results of biventricular pacing in heart failure: correlation between clinical hemodynamic data. PACE 2000; 23: 1713–7. [26] Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344; 873–80. [27] Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail 2000; 6: 369–80. [28] Abraham W. MIRACLE trial data. Presented at the North American Society of Pacing and Electrophysiology Meeting, Boston, 2001. [29] Leclerq C, Victor F, Alonso C et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol 2000; 85: 1154–6. [30] Lupi G, Brignole M, Oddone D et al. Effects of left ventricular pacing on cardiac performance and quality of life in patients with drug-refractory heart failure. Am J Cardiol 2000; 86: 33–6. [31] Leclercq C, Walker S, Linde C et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002; 23: 1780–1787. [32] Ansalone G, Giannantoni P, Ricci R et al. Doppler myocardial imaging in patients with heart failure receiving biventricular pacing treatment. Am Heart J 2001; 142: 881–96. [33] Twidale N, Manda V, Nave K et al. Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure. Am Heart J 1998; 136: 647–57. [34] Stellbrink C, Breithardt OL, Franke A et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001; 38: 1957–65. [35] Touiza A, Etienne Y, Gilard M et al. Long-term left ventricular pacing: assessment and comparison with biventricular pacing in patients with severe congestive heart failure. J Am Coll Cardiol 2001; 38: 1966–70. [36] Coman JA. Contak trial data. Presented at the North American Society of Pacing and Electrophysiology Meeting, Boston, 2001. [37] Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 21; 346: 877–83.